131 related articles for article (PubMed ID: 37307963)
1. S1PR2/Wnt3a/RhoA/ROCK1/β-catenin signaling pathway promotes diabetic nephropathy by inducting endothelial mesenchymal transition and impairing endothelial barrier function.
Zhang J; Chen S; Xiang H; Xiao J; Zhao S; Shu Z; Chai Y; Ouyang J; Liu H; Wang X; Quan Q; Fan J; Gao P; Chen AF; Lu H
Life Sci; 2023 Sep; 328():121853. PubMed ID: 37307963
[TBL] [Abstract][Full Text] [Related]
2. S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.
Wang X; Chen S; Xiang H; Wang X; Xiao J; Zhao S; Shu Z; Ouyang J; Liang Z; Deng M; Chen X; Zhang J; Liu H; Quan Q; Gao P; Fan J; Chen AF; Lu H
Biochem Pharmacol; 2022 Jul; 201():115077. PubMed ID: 35537530
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
[TBL] [Abstract][Full Text] [Related]
4. S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1.
Chen W; Xiang H; Chen R; Yang J; Yang X; Zhou J; Liu H; Zhao S; Xiao J; Chen P; Chen AF; Chen S; Lu H
BMC Nephrol; 2019 Apr; 20(1):135. PubMed ID: 30999892
[TBL] [Abstract][Full Text] [Related]
5. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.
Peng H; Li Y; Wang C; Zhang J; Chen Y; Chen W; Cao J; Wang Y; Hu Z; Lou T
Sci Rep; 2016 Feb; 6():20304. PubMed ID: 26842599
[TBL] [Abstract][Full Text] [Related]
6. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy.
Lu L; Zhong Z; Gu J; Nan K; Zhu M; Miao C
Mol Med; 2021 Jul; 27(1):74. PubMed ID: 34238215
[TBL] [Abstract][Full Text] [Related]
7. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
Liu F; Zhang S; Xu R; Gao S; Yin J
Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
[TBL] [Abstract][Full Text] [Related]
8. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy.
Guan G; Xie J; Dai Y; Han H
J Biol Chem; 2022 Mar; 298(3):101725. PubMed ID: 35157852
[TBL] [Abstract][Full Text] [Related]
9. Serum response factor induces endothelial-mesenchymal transition in glomerular endothelial cells to aggravate proteinuria in diabetic nephropathy.
Zhao L; Zhao J; Wang X; Chen Z; Peng K; Lu X; Meng L; Liu G; Guan G; Wang F
Physiol Genomics; 2016 Oct; 48(10):711-718. PubMed ID: 27565710
[TBL] [Abstract][Full Text] [Related]
10. SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy.
Wu M; Hao Y; Wu X; Zhu M; Chen X; Qi J; Yu Z; Xu H
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):586-596. PubMed ID: 38449390
[TBL] [Abstract][Full Text] [Related]
11. The SETD8/ELK1/bach1 complex regulates hyperglycaemia-mediated EndMT in diabetic nephropathy.
Li X; Lu L; Hou W; Wang F; Huang T; Meng Z; Zhu M
J Transl Med; 2022 Mar; 20(1):147. PubMed ID: 35351142
[TBL] [Abstract][Full Text] [Related]
12. NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic nephropathy.
Shang J; Zhang Y; Jiang Y; Li Z; Duan Y; Wang L; Xiao J; Zhao Z
Biochem Biophys Res Commun; 2017 Mar; 484(2):435-441. PubMed ID: 28137583
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes.
Yasuzawa T; Nakamura T; Ueshima S; Mima A
J Diabetes Res; 2021; 2021():2182225. PubMed ID: 34977254
[TBL] [Abstract][Full Text] [Related]
14. STAT5A modulated EndMT via upregulation of ELTD1 expression in diabetic nephropathy.
Tian Y; Bi Z; Ge S; Ye B; Han W
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):686-695. PubMed ID: 35320597
[TBL] [Abstract][Full Text] [Related]
15. S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function.
Xiong W; Chen S; Xiang H; Zhao S; Xiao J; Li J; Liu Y; Shu Z; Ouyang J; Zhang J; Liu H; Wang X; Zou H; Chen Y; Chen A; Lu H
Pulm Pharmacol Ther; 2023 Aug; 81():102228. PubMed ID: 37295666
[TBL] [Abstract][Full Text] [Related]
16. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
[TBL] [Abstract][Full Text] [Related]
17. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
18. Rhein Inhibited Ferroptosis and EMT to Attenuate Diabetic Nephropathy by Regulating the Rac1/NOX1/β-Catenin Axis.
Xiong D; Hu W; Han X; Cai Y
Front Biosci (Landmark Ed); 2023 May; 28(5):100. PubMed ID: 37258467
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression.
Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR
Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049
[TBL] [Abstract][Full Text] [Related]
20. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
